Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
9,049,455
-
Total 13F shares
-
379,488
-
Share change
-
+132,122
-
Total reported value
-
$545,311
-
Price per share
-
$1.44
-
Number of holders
-
14
-
Value change
-
+$177,416
-
Number of buys
-
8
-
Number of sells
-
5
Institutional Holders of BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX) as of Q3 2025
As of 30 Sep 2025,
BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
379,488 shares.
The largest 10 holders included
CITADEL ADVISORS LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, WEALTH ALLIANCE, LLC, StoneX Group Inc., Virtu Financial LLC, STATE STREET CORP, Tower Research Capital LLC (TRC), OSAIC HOLDINGS, INC., and WELLS FARGO & COMPANY/MN.
This page lists
14
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.